U.S. Markets closed

Roche Holding AG (RHHBY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
33.96-0.41 (-1.19%)
At close: 4:00PM EDT
People also watch
NVSSNYNSRGYAZNBAYRY

Roche Holding AG

Konzern-Hauptsitz
Grenzacherstrasse 124
Basel 4070
Switzerland
41 61 688 11 11
http://www.roche.com

Sector
Industry
Full Time Employees94,052

Key Executives

NameTitlePayExercisedAge
Dr. Severin Schwan Ph.D.Chief Exec. Officer and Exec. Director7.88MN/A50
Dr. Alan HippeChief Financial and IT Officer4.13MN/A50
Dr. Gottlieb A. KellerGen. Counsel and Corp. Sec.3.09MN/A63
Mr. Daniel O'DayChief Exec. Officer of Roche Pharmaceuticals6.61MN/A53
Mr. Roland DiggelmannChief Exec. Officer of Roche Diagnostics3.04MN/A50
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses worldwide. The company offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, human papillomavirus, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases. It also provides diagnostic solutions for blood gas analysis; blood screening; cancer screening; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring, routing, and specialty testing; data management; diabetes monitoring and therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogenous immune assays; immunology; infectious diseases; intensive care testing; microarray; anti-platelet therapy monitoring; neonatal intensive care; nucleic acid purification; PCR clinical diagnostics and real-time PCR diagnostic systems; pharmacogenomics; physical fitness and platelet function testing; serum work area; urinalysis; and workflow solutions. In addition, the company offers cell analysis, gene expression, genome sequencing, nucleic acid purification, and real-time PCR systems for researchers. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Corporate Governance

Roche Holding AG’s ISS Governance QualityScore as of May 1, 2017 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.